Literature DB >> 20704675

Vasomotor disturbances in complex regional pain syndrome--a review.

Gunnar Wasner1.   

Abstract

Complex regional pain syndromes (CRPS) are characterized by vascular disturbances primary affecting the microcirculation in the distal part of the involved extremity. In the acute stage inhibited sympathetic vasoconstriction and exaggerated neurogenic inflammation driven by central and peripheral mechanisms, respectively, seem to be the major pathophysiological mechanisms inducing vasodilation. During the chronic course of the disease as well as early in some patients vasoconstriction dominates the clinical picture induced by changes in the microcirculation itself such as endothelial dysfunction or vascular hyperreactivity, whereas sympathetic vasoconstrictor activity returns and neurogenic inflammation is less severe. It can be suggested that the interaction between different mechanisms underlying vasomotor disturbances as well as the severity of each single mechanism in the individual patient have a great impact on the variety of the overall clinical picture in CRPS. Irrespective of the underlying pathophysiology, measurements of skin temperature differences between the affected and the contralateral extremity can serve as a diagnostic tool in CRPS, in particular when sensitivity and specificity is increased by considering dynamic alterations in skin temperature asymmetries.

Entities:  

Mesh:

Year:  2010        PMID: 20704675     DOI: 10.1111/j.1526-4637.2010.00914.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  13 in total

1.  Responsiveness to botulinum toxin type A in muscles of complex regional pain patients with tonic dystonia.

Authors:  Johanna C M Schilder; J Gert van Dijk; Dirk Dressler; Johannes H T M Koelman; Johan Marinus; Jacobus J van Hilten
Journal:  J Neural Transm (Vienna)       Date:  2014-02-15       Impact factor: 3.575

2.  A possible role of the locus coeruleus in complex regional pain syndrome.

Authors:  Peter D Drummond
Journal:  Front Integr Neurosci       Date:  2012-11-08

3.  Fixed-site high-frequency transcutaneous electrical nerve stimulation for treatment of chronic low back and lower extremity pain.

Authors:  Shai N Gozani
Journal:  J Pain Res       Date:  2016-06-28       Impact factor: 3.133

4.  A Comprehensive Algorithm for Management of Neuropathic Pain.

Authors:  Daniel Bates; B Carsten Schultheis; Michael C Hanes; Suneil M Jolly; Krishnan V Chakravarthy; Timothy R Deer; Robert M Levy; Corey W Hunter
Journal:  Pain Med       Date:  2019-06-01       Impact factor: 3.750

5.  Searching for hidden, painful osteochondral lesions of the ankle in patients with chronic lower limb pain - two case reports -.

Authors:  Hyun Su Ri; Dong Heon Lee; Kyung Hoon Kim
Journal:  Korean J Pain       Date:  2013-04-03

6.  Investigating Reports of Complex Regional Pain Syndrome: An Analysis of HPV-16/18-Adjuvanted Vaccine Post-Licensure Data.

Authors:  Frank Huygen; Kristin Verschueren; Candida McCabe; Jens-Ulrich Stegmann; Julia Zima; Olivia Mahaux; Lionel Van Holle; Maria-Genalin Angelo
Journal:  EBioMedicine       Date:  2015-07-06       Impact factor: 8.143

7.  Acute and chronic phases of complex regional pain syndrome in mice are accompanied by distinct transcriptional changes in the spinal cord.

Authors:  Joseph J Gallagher; Maral Tajerian; Tianzhi Guo; Xiaoyou Shi; Wenwu Li; Ming Zheng; Gary Peltz; Wade S Kingery; J David Clark
Journal:  Mol Pain       Date:  2013-08-08       Impact factor: 3.395

8.  Complex regional pain syndrome in a competitive athlete and regional osteoporosis assessed by dual-energy X-ray absorptiometry: a case report.

Authors:  Karen Hind; Mark I Johnson
Journal:  J Med Case Rep       Date:  2014-05-27

Review 9.  Sympathetic nervous system and chronic bladder pain: a new tune for an old song.

Authors:  Ana Charrua; Rui Pinto; Lori Ann Birder; Francisco Cruz
Journal:  Transl Androl Urol       Date:  2015-10

10.  Contribution of Piezo2 to endothelium-dependent pain.

Authors:  Luiz F Ferrari; Oliver Bogen; Paul Green; Jon D Levine
Journal:  Mol Pain       Date:  2015-10-24       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.